Penelope Pearl Langer has been working as a Scientist Innovative Formulations at HWI Group since June 2022. Prior to that, Penelope Pearl worked as a Chemielaborant at Sofotec GmbH - A member of the AstraZeneca Group, focusing on Inhalation Product Development from July 2020 to June 2022. Before entering the pharmaceutical industry, Penelope gained experience as a Chemielaborant at Clariant from September 2017 to June 2020. Penelope Pearl completed their Chemielaborant degree at Paul-Ehrlich-Schule and obtained a Fachhochschulreife in Gestaltung from Hochtaunusschule.
View in org chart
View in org chart
June, 2022 - present
Manager, Laboratory Transitions And Practice Operations at American Oncology Network
Product Team Lead, Machine Learning Platforms, CTO AI Strategy & Research at Bloomberg
Senior Research Fellow at University of Oxford
Vice President And Head Global Health Economics And Outcomes Research (heor) at Bristol-Myers Squibb
Lab Recruiter at Triage Staffing